Form 4: Arteris CEO Charles Janac Sells Small Portion of Shares Under Pre-Arranged Trading Plan

Arteris, Inc. President and CEO, Charles Janac, reported the sale of 2,057 shares of common stock on June 4, 2025, as part of a pre-established 10b5-1 trading plan.

Summary

• Charles Janac, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported a transaction on June 4, 2025.
• The transaction involved the sale of 2,057 shares of Arteris Common Stock at a weighted average price of $7.828 per share, with prices ranging from $7.75 to $8.01.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Janac on February 27, 2024.
• Following this transaction, Mr. Janac directly beneficially owns 305,664 shares of Common Stock.
• Additionally, Mr. Janac indirectly beneficially owns 9,907,691 shares through Bayview Legacy, LLC, where he is the manager, and 56,252 shares through the Charles and Lydia Janac Trust, for which he serves as trustee, totaling 9,963,943 indirect shares.
• The total beneficial ownership for Mr. Janac after the reported transaction is 10,269,607 shares (305,664 direct + 9,963,943 indirect).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's an insider sale, it was executed under a pre-arranged 10b5-1 plan, which mitigates any negative perception of insider selling. The small volume relative to total holdings also suggests it's for personal financial management rather than a reflection of company outlook.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market, though the impact is mitigated by the 10b5-1 plan.

Risks

• While the sale was pre-planned, continuous insider selling could potentially signal a lack of confidence, though this single, small transaction is unlikely to have such an implication.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The transaction was made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 27, 2024.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide specific insights into broader industry trends or competitive landscape for Arteris, Inc., which operates in the semiconductor intellectual property (IP) and Network-on-Chip (NoC) interconnect technology sector.

Corporate Governance

Related Party Transactions

• Charles Janac's indirect beneficial ownership includes shares held by Bayview Legacy, LLC, where he is the manager, and shares held by the Charles and Lydia Janac Trust, for which he serves as trustee. These are considered related party holdings.

Stakeholder Impact

• Shareholders: The sale is a small percentage of the CEO's total holdings and was pre-planned, so it is unlikely to have a significant impact on shareholder confidence or the stock price.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Arteris, AIP, Form 4, Insider Trading, Stock Sale, Beneficial Ownership, CEO, Director, 10b5-1 Plan, Semiconductor IP, Network-on-Chip